Drawing for VERGENIX

USPTO serial 87458500

VERGENIX

Reviewed by CopyMark Law Group

Reg. 5467317Status 710
Filing date
Status date
Registration date
May 15, 2018
Examiner
LIU, PHILIP HUAI-EN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with VERGENIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Abigail Rubinstein

ABIGAIL RUBINSTEIN WEISS & ARONS LLP1540 ROUTE 202SUITE 8POMONA, NY 10970

Goods and services

ClassDescriptionStatusFirst use
001Chemical and bio-chemical product, namely, recombinant collagen from plants used as a raw ingredient in the manufacture of cosmetic preparations for skin care, skin moisturizing gel, and non-medicated anti-aging serum for use in the cosmetic industry, no uses are related to cancer and excluding products in relation to wartsSECTION 8 - CANCELLED—
003Product containing quality human recombinant collagen from plants, namely, non-medicated skin cream and skin moisturizing gels for cosmetic purposes, no uses are related to cancer and excluding products in relation to wartsSECTION 8 - CANCELLED—
005Product containing quality human recombinant collagen from plants, namely, medicated ointment and gel for the skin for treating dermatological conditions and injectable dermal filler for medical and pharmaceutical uses, no uses are related to cancer and excluding products in relation to wartsSECTION 8 - CANCELLED—
010Product containing quality human recombinant collagen from plants for medical and pharmaceutical uses, applications and preparations, namely, implantable 3D scaffolds comprising artificial materials for maintaining tissue contour for hard and soft tissue repair and bioink for 3D printing of tissues and organs, no uses are related to cancer and excluding products in relation to wartsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 29, 2024C8..CANCELLED SEC. 8 (6-YR)—
May 15, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 15, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 27, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 27, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 7, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 24, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 11, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jan 11, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 11, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 11, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 7, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 7, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 4, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 12, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 12, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Oct 12, 2017CNSLSUSPENSION LETTER WRITTEN—
Sep 27, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 27, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 25, 2017ALIEASSIGNED TO LIE—
Sep 17, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 26, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 26, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 26, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2017DOCKASSIGNED TO EXAMINER—
May 26, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 25, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance